Peer-influenced content. Sources you trust. No registration required. This is HCN.
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
HIT Consultant
Philips Respironics has established a consent decree with US regulators to ensure the safety and compliance of their sleep and respiratory care devices, focusing on stringent remediation and continued patient support amidst ongoing sales restrictions.
Internal Medicine April 22nd 2024
MDLinx
With a significant rise in meningococcal disease cases in 2023 and continuing into 2024, physicians must be alert for non-traditional symptoms such as septic arthritis and bacteremia to ensure timely and effective patient management.
Infectious Diseases April 18th 2024
Medical Professionals Reference (MPR)
Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.
Medical News Today (MNT)
This study highlights the importance of evaluating the nutritional content of plant-based meat substitutes as they compare closely with traditional meats in terms of cardiometabolic health outcomes, with neither showing clear benefits over the other.
Cardiology April 17th 2024
Cleveland Clinic Journal of Medicine
In managing acute decompensated heart failure, optimizing loop diuretic therapy is pivotal; initial aggressive dosing tailored to urinary outputs can significantly improve patient outcomes.